We understand that today’s life sciences companies face many challenges including; a substantial demographic shift in the age profile of populations, pricing and reimbursement pressures, high hurdles for innovation, changes in the approach to disease management towards early diagnosis and prevention, the entry of new technologies, the ever increasing and burgeoning cost of healthcare provision and the ongoing global economic crisis.